S&P 500   3,661.63 (-0.02%)
DOW   29,793.58 (-0.10%)
QQQ   303.85 (+0.13%)
AAPL   123.36 (+0.52%)
MSFT   214.37 (-0.85%)
FB   288.71 (+0.75%)
GOOGL   1,828.94 (+1.87%)
AMZN   3,217.50 (-0.08%)
TSLA   561.42 (-3.99%)
NVDA   543.67 (+1.51%)
BABA   261.76 (-0.85%)
CGC   28.43 (+6.68%)
GE   10.36 (+2.07%)
MU   68.45 (+2.04%)
AMD   94.26 (+1.76%)
T   28.94 (+0.24%)
NIO   46.50 (+2.51%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   504.18 (-0.08%)
BA   218.96 (+2.79%)
GILD   61.23 (+0.18%)
DIS   152.47 (+2.03%)
S&P 500   3,661.63 (-0.02%)
DOW   29,793.58 (-0.10%)
QQQ   303.85 (+0.13%)
AAPL   123.36 (+0.52%)
MSFT   214.37 (-0.85%)
FB   288.71 (+0.75%)
GOOGL   1,828.94 (+1.87%)
AMZN   3,217.50 (-0.08%)
TSLA   561.42 (-3.99%)
NVDA   543.67 (+1.51%)
BABA   261.76 (-0.85%)
CGC   28.43 (+6.68%)
GE   10.36 (+2.07%)
MU   68.45 (+2.04%)
AMD   94.26 (+1.76%)
T   28.94 (+0.24%)
NIO   46.50 (+2.51%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   504.18 (-0.08%)
BA   218.96 (+2.79%)
GILD   61.23 (+0.18%)
DIS   152.47 (+2.03%)
S&P 500   3,661.63 (-0.02%)
DOW   29,793.58 (-0.10%)
QQQ   303.85 (+0.13%)
AAPL   123.36 (+0.52%)
MSFT   214.37 (-0.85%)
FB   288.71 (+0.75%)
GOOGL   1,828.94 (+1.87%)
AMZN   3,217.50 (-0.08%)
TSLA   561.42 (-3.99%)
NVDA   543.67 (+1.51%)
BABA   261.76 (-0.85%)
CGC   28.43 (+6.68%)
GE   10.36 (+2.07%)
MU   68.45 (+2.04%)
AMD   94.26 (+1.76%)
T   28.94 (+0.24%)
NIO   46.50 (+2.51%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   504.18 (-0.08%)
BA   218.96 (+2.79%)
GILD   61.23 (+0.18%)
DIS   152.47 (+2.03%)
S&P 500   3,661.63 (-0.02%)
DOW   29,793.58 (-0.10%)
QQQ   303.85 (+0.13%)
AAPL   123.36 (+0.52%)
MSFT   214.37 (-0.85%)
FB   288.71 (+0.75%)
GOOGL   1,828.94 (+1.87%)
AMZN   3,217.50 (-0.08%)
TSLA   561.42 (-3.99%)
NVDA   543.67 (+1.51%)
BABA   261.76 (-0.85%)
CGC   28.43 (+6.68%)
GE   10.36 (+2.07%)
MU   68.45 (+2.04%)
AMD   94.26 (+1.76%)
T   28.94 (+0.24%)
NIO   46.50 (+2.51%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   504.18 (-0.08%)
BA   218.96 (+2.79%)
GILD   61.23 (+0.18%)
DIS   152.47 (+2.03%)
Log in
ARCA:XTNT

Xtant Medical Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume7.22 million shs
Market Capitalization$21.58 million
P/E RatioN/A
Dividend YieldN/A
Beta1.6
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DMB Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation system; Spider cervical plating system; Axle Interspinous Fusion System; Silex Sacroiliac joint fusion system; Xpress minimally invasive pedicle screw system; and Fortex Pedicle screw system. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.33 out of 5 stars


Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone406 388 0480
Employees141

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$64.68 million
Book Value($3.36) per share

Profitability

Net Income$-8,220,000.00

Miscellaneous

Market Cap$21.58 million
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive XTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for XTNT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Xtant Medical (ARCA:XTNT) Frequently Asked Questions

What stocks does MarketBeat like better than Xtant Medical?

Wall Street analysts have given Xtant Medical a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Xtant Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Xtant Medical's key competitors?

Who are Xtant Medical's key executives?

Xtant Medical's management team includes the following people:
  • Mr. Sean E. Browne, Pres, CEO & Director (Age 54, Pay $665.08k)
  • Mr. Greg Jensen, VP of Fin. & CFO (Age 59, Pay $544.16k)
  • Mr. Kevin D. Brandt, Sr. VP & Chief Commercial Officer (Age 54, Pay $629.65k)
  • Ms. Catherine Lundy, VP of HR
  • Mr. Kevin M. O'Dare, VP of Sales - Eastern US

What is Xtant Medical's stock symbol?

Xtant Medical trades on the ARCA under the ticker symbol "XTNT."

How do I buy shares of Xtant Medical?

Shares of XTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

How big of a company is Xtant Medical?

Xtant Medical has a market capitalization of $0.00 and generates $64.68 million in revenue each year. Xtant Medical employs 141 workers across the globe.

What is Xtant Medical's official website?

The official website for Xtant Medical is www.xtantmedical.com.

How can I contact Xtant Medical?

The company can be reached via phone at 406 388 0480.

This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.